Pharmaceutical use of cord blood derived immunosuppressing cells

The present invention relates to the pharmaceutical use of a cord blood immunosuppressive cell and, more specifically, the present invention provides the use of a human-derived cord blood immunosuppressive cell, which is selected in accordance with analysis of function and phenotype and a classifica...

Full description

Saved in:
Bibliographic Details
Main Authors LIM BANG GEUL, KIM TAI GYU, JUNG SOO HYUN, KIM EUN AH, SOHN HYUN JUNG, CHO HYUN IL, KIM SU EON
Format Patent
LanguageEnglish
Korean
Published 21.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the pharmaceutical use of a cord blood immunosuppressive cell and, more specifically, the present invention provides the use of a human-derived cord blood immunosuppressive cell, which is selected in accordance with analysis of function and phenotype and a classification standard, as a novel cell therapy product for anti-inflammation, anti-fibrosis, and prevention or treatment of myocardial infarction. 본 발명은 제대혈면역억제세포의 약제학적 용도에 관한 것으로, 보다 상세하게는, 본 발명은 기능과 표현형의 분석 및 구분 기준에 따라 선별된 인간 유래 제대혈면역억제세포의 항염증, 항섬유화, 심근경색의 예방 또는 치료를 위한 새로운 세포치료제로서의 용도를 제공한다.
Bibliography:Application Number: KR20210076613